Despite India’s rising cancer cases, a breakthrough treatment brings hope! For patients with specific types of aggressive B-cell Non-Hodgkin Lymphoma that have not responded to standard treatments, advanced options like CAR T-cell therapy are emerging. For instance, India's indigenous NexCAR19 therapy showed a 73% response rate in a clinical trial for this specific patient group.
The typical treatment of lymphoma uses a combination of therapies, chosen based on the type, stage, and severity of the disease. In India, the most widely used treatment options are:
Chemotherapy involves the use of anti-cancer drugs to kill cancer cells and is the most common treatment for lymphoma. Doctors usually administer it in cycles over several months.
Estimated Cost: Rs. 40,000 – Rs. 1,50,000 per cycle.
Radiotherapy uses high-energy radiation to target and destroy cancer cells. Doctors often use radiotherapy in early-stage lymphoma or combination with chemotherapy.
Estimated Cost: Rs. 60,000 – Rs. 2,50,000 for a complete course.
Targeted therapy uses specialised drugs that attack specific proteins or genes in cancer cells while sparing healthy cells. Doctors commonly recommend this in advanced or resistant cases.
Estimated Cost: Rs. 1,80,000 – Rs. 3,50,000 per month or per cycle, depending on the drug and regimen.
This treatment boosts the body's immune system to help it recognise and destroy cancer cells. Doctors frequently use monoclonal antibodies, such as Rituximab, especially to treat Non-Hodgkin Lymphoma (NHL).
Estimated Cost: Rs. 25,000 – Rs. 4,50,000 per cycle (cost varies significantly based on the specific drug and dosage).
Used in advanced or relapsed cases, this procedure replaces damaged bone marrow with healthy stem cells to restore the body’s ability to produce blood cells.
Estimated Cost: Rs. 8,00,000 – Rs. 40,00,000.
CAR T-cell therapy is an advanced option for treating aggressive B-cell NHL unresponsive to standard treatments. It modifies a patient's T-cells to target cancer cells. India's innovations, such as NexCAR19, have made this life-saving therapy more accessible and affordable.
Estimated Cost: Rs. 30,00,000 – Rs. 40,00,000.
PET/CT scans, blood tests, biopsies, and regular medical consultations are essential throughout the treatment journey. Hospital stays and supportive care also contribute to the overall cost.
Estimated Cost:
Disclaimer: The costs mentioned are approximate and may vary. For accurate and up-to-date pricing, please consult your hospital or healthcare provider directly to ensure transparency.
Lymphoma is a form of cancer that can be broadly classified into two main types: Hodgkin's Lymphoma and Non-Hodgkin Lymphoma (NHL). The treatment cost depends on various factors such as the type of lymphoma, the stage at diagnosis, and the chosen course of treatment.
While India offers more affordable cancer care compared to many Western countries, the financial burden can still be considerable and varies significantly based on individual cases.